Prestige Wealth Management Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Hold |
159
| – | – | ﹤0.01% | 348 |
|
|
2025
Q1 | $20.3K | Sell |
159
-60
| -27% | -$7.67K | ﹤0.01% | 338 |
|
|
2024
Q4 | $29K | Hold |
219
| – | – | 0.01% | 317 |
|
|
2024
Q3 | $31.9K | Hold |
219
| – | – | 0.01% | 294 |
|
|
2024
Q2 | $30.1K | Hold |
219
| – | – | 0.01% | 272 |
|
|
2024
Q1 | $30.1K | Hold |
219
| – | – | 0.01% | 300 |
|
|
2023
Q4 | $29.8K | Hold |
219
| – | – | 0.01% | 295 |
|
|
2023
Q3 | $26.8K | Hold |
219
| – | – | 0.01% | 298 |
|
|
2023
Q2 | $27.8K | Sell |
219
-4
| -2% | -$508 | 0.01% | 319 |
|
|
2023
Q1 | $28.8K | Sell |
223
-32
| -13% | -$4.13K | 0.01% | 288 |
|
|
2022
Q4 | $33.5K | Sell |
255
-87
| -25% | -$11.4K | 0.01% | 290 |
|
|
2022
Q3 | $40K | Sell |
342
-10
| -3% | -$1.17K | 0.01% | 243 |
|
|
2022
Q2 | $41K | Sell |
352
-19,894
| -98% | -$2.32M | 0.01% | 254 |
|
|
2022
Q1 | $2.64M | Buy |
20,246
+651
| +3% | +$84.8K | 0.65% | 28 |
|
|
2021
Q4 | $2.99M | Buy |
19,595
+1,899
| +11% | +$290K | 0.71% | 24 |
|
|
2021
Q3 | $2.86M | Buy |
17,696
+672
| +4% | +$109K | 0.73% | 27 |
|
|
2021
Q2 | $2.79M | Buy |
17,024
+7
| +0% | +$1.15K | 0.74% | 26 |
|
|
2021
Q1 | $2.56M | Buy |
17,017
+436
| +3% | +$65.6K | 0.7% | 27 |
|
|
2020
Q4 | $2.51M | Buy |
16,581
+4,620
| +39% | +$700K | 0.69% | 26 |
|
|
2020
Q3 | $1.62M | Buy |
+11,961
| New | +$1.62M | 0.49% | 27 |
|
|
2020
Q1 | – | Sell |
-10
| Closed | -$1K | – | 950 |
|
|
2019
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 534 |
|